Olfactory Testing in Parkinson Disease and REM Behavior Disorder: A Machine Learning Approach

Christine Lo1, Siddharth Arora2, Yoav Ben-Shlomo2

  • 1From the Oxford Parkinson's Disease Centre (C.L., S.A., T.R.B., J.C.K., M.T.H.), Nuffield Department of Clinical Neurosciences (C.L., T.R.B., J.C.K., M.T.H.), and Saïd Business School (S.A.), University of Oxford; Population Health Sciences (Y.B.-S., M.L., S.K.), University of Bristol, UK; Department of Neurology (A.J., E.S., W.H.O.), Philipps University Marburg; Institute for Neurogenomics (W.H.O.), München Helmholtz Center for Health and Environment, Neuherberg München, Germany; and Institute of Neurological Sciences (D.G.G.), Queen Elizabeth University Hospital, Glasgow, UK. Christine.lo@nhs.net.

Neurology
|February 25, 2021
PubMed
Summary

A brief, 3-item olfactory test effectively identifies impaired smell in Parkinson disease (PD) and isolated REM sleep behavior disorder (iRBD). This screening tool aids in early detection and stratification of neurodegenerative conditions.